The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
AKRO
What does the director see there?
A director at AKRO, a company developing drugs for metabolic and rare diseases, made a large stock purchase worth $8.7 million!
Other Stories
Super unusual activity in a small and dangerous company!
PremiumInsidersTENX12h ago2 min read
5 investment firms cut targets, and the executive bought anyway. Since then: 92.6% increase
PremiumInsidersNIQ13h ago2 min read
Unusual insider buying alert
PremiumInsidersINBX14h ago2 min read